BioXcel Therapeutics Inc (BTAI.O)

+ 收藏

财务摘要(报告期)(BioXcel Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -0.99-0.87-6.15-5.40-3.68-1.84-5.92-3.96-2.47-1.12
 每股净资产(元) -1.84-2.15-1.89-1.390.201.832.734.535.866.93
 每股经营现金净流量(元) -1.01-0.53-5.18-4.38-3.09-1.80-4.81-3.45-2.34-1.16
 每股现金流量净额(元) -0.220.27-4.29-3.54-2.26-0.97-1.39-0.020.02-1.16
 每股营业收入(元) 0.040.020.050.030.020.010.01---
盈利能力:
 销售毛利率(%) 91.6486.258.7045.6294.8795.6394.6791.97--
 销售净利率(%) -2,081.26-4,603.26-12,974.86-15,617.23-16,034.84-25,629.13-44,201.87-80,984.67--
 净资产收益率平均(%) 53.6541.58-1,766.94-867.07-257.29-81.36-111.08-63.64-35.83-15.14
 总资产净利率(%) -50.44-34.34-128.10-102.38-61.46-27.36-74.45-45.82-28.36-13.97
 投入资本回报率ROIC(%) -397.73-321.56-1,737.62-1,386.60-861.52-395.33-1,782.43-1,169.42-650.63-368.50
收益质量:
 营业利润/利润总额(%) 118.1590.1995.9496.8897.4696.9796.3196.2298.01100.03
 经营活动产生的现金流量净额/营业收入(%) -2,424.67-3,042.27-11,232.32-12,763.25-13,658.97-25,414.08-36,090.93-70,585.40--
资本结构:
 资产负债率(%) 213.55187.90176.67140.4395.8170.5762.7048.1333.838.07
 权益乘数 -0.88-1.14-1.30-2.4723.893.402.681.931.511.09
 产权比率 -1.88-2.14-2.30-3.4722.892.401.680.930.510.09
 流动资产/总资产(%) 98.0898.2997.8898.3098.6798.4398.5598.7198.6798.35
 非流动资产/总资产(%) 1.921.712.121.701.331.571.451.291.331.65
 流动负债/负债合计(%) 19.5320.3520.9427.9425.8822.6325.4919.8423.8193.96
 非流动负债/负债合计(%) 80.4779.6579.0672.0674.1277.3774.5180.1676.196.04
 归属母公司股东的权益/投入资本(%) -810.79-884.42-666.29-387.1946.72363.50633.041,015.561,111.151,828.65
偿债能力:
 流动比率 2.352.572.652.513.986.166.1710.3412.2512.98
 速动比率 2.252.492.572.453.926.106.1110.2812.1812.93
 货币资金/流动负债(%) 206.21235.51239.19228.28367.10575.55588.87993.731,167.551,252.95
 营业利润/流动负债(%) -151.93-76.75-630.00-385.47-298.21-178.02-485.27-456.63-338.92-196.79
 经营活动产生的现金流量净额/流动负债(%) -149.81-56.24-568.47-325.17-260.65-182.04-411.40-413.65-327.66-202.62
 归属母公司股东的权益/负债合计(%) -53.17-46.78-43.40-28.794.3741.7059.48107.77195.611,139.62
 经营活动产生的现金流量净额/负债合计(%) -29.26-11.45-119.04-90.84-67.46-41.19-104.85-82.07-78.02-190.38
 营业利润/负债合计(%) -29.67-15.62-131.93-107.69-77.19-40.28-123.68-90.60-80.70-184.90
成长能力:
 总资产同比增长率(%) -53.29-54.29-64.20-58.97-43.56-14.66-14.03-6.32-11.695.32
 每股净资产同比增长率(%) -1,018.30-217.76-169.22-130.61-96.58-73.65-65.57-48.37-38.68-8.53
 总负债同比增长率(%) 4.1021.710.8819.7159.85646.54626.30646.91513.1224.71
 基本每股收益同比增长率(%) 73.1052.72-3.89-36.36-48.99-64.29-46.17-26.52-13.30-3.70
 归属母公司股东的权益同比增长率(%) -1,367.07-236.52-173.60-131.98-96.43-72.68-65.36-48.29-38.573.90
 营业利润同比增长率(%) 59.9952.80-7.60-42.30-52.89-62.64-49.29-32.11-25.51-19.34
 营业收入同比增长率(%) 154.30182.52268.00632.85------
 股东权益合计同比增长率(%) -1,367.07-236.52-173.60-131.98-96.43-72.68-65.36-48.29-38.573.90
营运能力:
 存货周转率次(次) 0.060.040.630.270.02-0.020.02--
 流动资产周转率次(次) 0.020.010.010.01------
 固定资产周转率次(次) 2.390.781.481.030.650.200.320.11--
 总资产周转率次(次) 0.020.010.010.01------
衍生指标:
 现金及现金等价物净增加额TTM(元) -71,274,000.00-91,380,000.00-128,504,000.00-142,353,000.00-105,907,000.00-34,914,000.00-39,243,000.00-20,598,000.00-39,605,000.006,420,000.00
 利润总额TTM(元) -107,832,000.00-153,048,000.00-179,053,000.00-211,605,000.00-202,926,000.00-187,081,000.00-165,757,000.00-137,074,000.00-122,078,000.00-112,027,000.00
 毛利TTM(元) 1,036,000.00425,000.00120,000.00687,000.00355,000.00355,000.00355,000.00---
 投入资本(元) 9,164,000.008,182,000.008,481,000.0010,488,000.0012,552,000.0014,582,000.0012,128,000.0012,504,000.0014,783,000.0010,610,000.00
 经营活动产生的现金流量净额TTM(元) -105,327,000.00-120,359,000.00-155,006,000.00-166,782,000.00-160,384,000.00-155,281,000.00-135,341,000.00-116,634,000.00-105,647,000.00-94,926,000.00
 总营业收入TTM(元) 2,403,000.001,756,000.001,380,000.001,242,000.00375,000.00375,000.00375,000.00---
 归属母公司净利润TTM(元) -107,832,000.00-153,048,000.00-179,053,000.00-211,605,000.00-202,926,000.00-187,081,000.00-165,757,000.00-137,074,000.00-122,078,000.00-112,027,000.00

前瞻产业研究院